Showing results (2921-2930 of 3,091) with videos related to

Sort By:
Pageof 310
Drug Safety|February 28, 2008
Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacinJean-Philippe Couderc, Scott McNitt, Ollivier Hyrien, et al.
Drug Safety|April 25, 2014
Impact of interventions designed to reduce medication administration errors in hospitals: a systematic reviewRichard N Keers, Steven D Williams, Jonathan Cooke, et al.
Drug Safety|March 15, 2014
Performance of probabilistic method to detect duplicate individual case safety reportsPhilip Michael Tregunno, Dorthe Bech Fink, Cristina Fernandez-Fernandez, et al.
Drug Safety|April 1, 2014
Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillationSascha Meyer Dos Santos, Sebastian Harder
Drug Safety|April 4, 2014
Managing medicinal risks in self-medicationSylvie Fainzang
Drug Safety|April 8, 2014
Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux diseaseJaroslaw Kierkus, Grzegorz Oracz, Bartosz Korczowski, et al.
Drug Safety|May 20, 2008
Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance studyMartin C Michel, Ulrich Wetterauer, Monika Vogel, et al.
Drug Safety|May 20, 2008
Adverse drug reaction reporting by patients in the Netherlands: three years of experienceJoyce de Langen, Florence van Hunsel, Anneke Passier, et al.
Drug Safety|May 20, 2008
Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case-control study in SpainElvira Rodríguez-Pinilla, Consuelo Mejías, David Prieto-Merino, et al.
Drug Safety|May 20, 2008
Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patientsMarilisa Franceschi, Carlo Scarcelli, Valeria Niro, et al.
Pageof 310